CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −6,613 | $0.88 | $6K | 601,564 |
| 2023-03-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −6,400 | $0.88 | $6K | 595,164 |
| 2023-03-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −1,110 | $0.88 | $974 | 594,054 |
| 2023-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −8,058 | $0.88 | $7K | 281,869 |
| 2023-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −10,476 | $0.88 | $9K | 271,393 |
| 2023-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −1,878 | $0.88 | $2K | 269,515 |
| 2023-03-01 | Spellman David A SVP, CFO and Treasurer | Sale | −6,400 | $0.88 | $6K | 510,860 |
| 2023-03-01 | Spellman David A SVP, CFO and Treasurer | Sale | −810 | $0.88 | $711 | 510,050 |
| 2023-02-27 | Butler John P. CEO and President | Sale | −38,632 | $0.81 | $31K | 1,660,740 |
| 2023-02-27 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −7,539 | $0.81 | $6K | 608,177 |
| 2023-02-27 | Dahan Michel SVP, Chief Operating Officer | Sale | −10,090 | $0.81 | $8K | 289,927 |
| 2023-02-27 | Spellman David A SVP, CFO and Treasurer | Sale | −7,539 | $0.81 | $6K | 517,260 |
| 2023-02-27 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −6,677 | $0.81 | $5K | 300,564 |
| 2023-01-31 | Butler John P. CEO and President | Grant or award | +293,125 | 1,699,372 | ||
| 2023-01-31 | Butler John P. CEO and President | Grant or award · Stock Appreciation Right | +635,313 | 635,313 | ||
| 2023-01-31 | Butler John P. CEO and President | Grant or award · Stock Option (Right to buy) | +875,000 | 875,000 | ||
| 2023-01-31 | Spellman David A SVP, CFO and Treasurer | Grant or award | +196,200 | 524,799 | ||
| 2023-01-31 | Spellman David A SVP, CFO and Treasurer | Grant or award · Stock Option (Right to buy) | +294,300 | 294,300 | ||
| 2023-01-31 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +196,200 | 615,716 | ||
| 2023-01-31 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +294,300 | 294,300 |
Page 9 of 21 · 405 trades